2C-B-aminorex
Appearance
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H13BrN2O3 |
Molar mass | 301.140 g·mol−1 |
3D model (JSmol) | |
| |
|
2C-B-aminorex (2C-B-AR) is a recreational designer drug with psychedelic effects. It is a substituted aminorex derivative which was first identified in Sweden in June 2019.[1] Structurally, it is a hybrid of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and aminorex.[2]
See also
[edit]- 2C-B
- 2C-B-PP
- BOB (psychedelic)
- 4,4'-DMAR
- 4'-Fluoro-4-methylaminorex
- 4B-MAR
- 4C-MAR
- List of aminorex analogues
References
[edit]- ^ Evans-Brown M, Gallegos A, Christie R, Jorge R, De Morais J, Almeida A, et al. (December 2020). New Psychoactive Substances: Global Markets, Glocal Threats and the COVID-19 Pandemic. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-557-7.
- ^ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18): 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.